Recent Updates
Recently added Catalysts
CLDX Positive Sentiment Score: 70/100

Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference

Monday, November 27, 2023 1 min read
Key Takeaway: Celldex Therapeutics, Inc. announced its participation in the 6th Annual Evercore ISI HealthCONx Conference on November 28th. The event will feature a fireside chat with management, and a webcast will be available for viewing. This participation highlights the company's ongoing efforts to present its clinical advancements and engage with the investment community.

Market Sentiment Analysis

POSITIVE FACTORS

  • Celldex Therapeutics is actively engaging with investors and stakeholders.
  • Participation in a respected conference indicates confidence in their pipeline.
  • The company's innovative approach to therapeutics shows potential for significant impact.

Full Press Release Details

HAMPTON, N.J., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28th at 5:05 pm ET. A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic and autoimmune and other devastating diseases. Visit www.celldex.com
Senior Vice President, Corporate Affairs & Administration
scavanaugh@celldex.com
ptill@meruadvisors.com

Frequently Asked Questions

When will Celldex participate in the health conference?

Celldex will participate in the Evercore ISI HealthCONx Conference on November 28th at 5:05 pm ET.

Where can I watch the Celldex presentation?

The presentation can be viewed on the 'Events & Presentations' page of Celldex's website.

How long will the presentation replay be available?

The replay of the presentation will be accessible for 90 days after the event.

What type of company is Celldex Therapeutics?

Celldex Therapeutics is a clinical stage biotechnology company focused on mast cell biology.

What is Celldex's research focus?

Celldex develops antibody-based therapeutics for severe inflammatory and autoimmune diseases.

Tags: CLDX Viatris Investor Conferences Healthcare Celldex Therapeutics Evercore ISI health conference clinical stage biotechnology
Last updated: Nov 27, 2023